News

Join Sequana Medical at VFB Happening: Future of Healthcare

Join Sequana Medical at VFB Happening: Future of Healthcare

Sequana Medical's Participation at VFB Happening 2025

Sequana Medical NV is excited to announce its participation in the VFB Happening 2025, an influential event showcasing innovation in the healthcare sector. Taking place in the renowned Congress Center ICC in Ghent, the event offers a fantastic opportunity for investors and industry leaders to connect and discuss upcoming trends and technologies.

Insights from Industry Leaders

At this year's VFB Happening, Sequana Medical will feature its leadership team at booth 3060, where discussions and insights will focus on the company’s breakthrough solutions to combat drug-resistant fluid overload. Attendees will have the chance to meet CEO Ian Crosbie and CFO, who will present critical updates regarding the upcoming U.S. launch of the alfapump, slated for mid-Q3.

Understanding Fluid Overload and Its Impacts

Fluid overload is a serious issue faced by patients with liver disease, heart failure, and cancer, presenting significant challenges such as increased mortality and frequent hospitalizations. Traditional diuretics often become ineffective or intolerable over time, leaving limited treatment options that impact patients’ quality of life.

Innovative Approaches by Sequana Medical

Sequana Medical is committed to developing innovative treatments for the millions of individuals affected by diuretic-resistant fluid overload. Its proprietary technologies, the alfapump and DSR, are designed to tackle fluid retention effectively while minimizing healthcare costs. These platforms aim to enhance patient outcomes dramatically.

Recent Developments and Future Plans

The company achieved a significant milestone with the FDA's approval of the alfapump System for treating recurrent ascites linked to liver cirrhosis. Following the FDA's Breakthrough Device Designation granted earlier, Sequana Medical is poised to start U.S. commercialization in mid-Q3 2025, targeting the country’s major liver transplant centers.

Clinical Success and Evidenced Benefits

Recent studies, including the RED DESERT and SAHARA trials published in a leading medical journal, have demonstrated how the DSR platform effectively interrupts the cycle of cardiorenal syndrome. Initial results from a Phase 1/2a clinical study involving three patients receiving DSR treatment revealed a remarkable improvement in patient outcomes, reducing dependency on loop diuretics significantly.

Getting Involved: Registration and Contact Information

Attendance at the VFB Happening is complimentary, but interested individuals must register in advance. This annual conference is a prime opportunity for investors and stakeholders to discover cutting-edge advancements in medical technology and engage with experts like the Sequana Medical team.

For those seeking to learn more or arrange a meeting, please reach out directly:

Contact Sequana Medical:
Investor Relations
Email: IR@sequanamedical.com
Phone: +32 9 292 8065

Frequently Asked Questions

1. What is the VFB Happening 2025?

The VFB Happening 2025 is Belgium’s leading investor conference, offering insights into advancements in healthcare.

2. Who will represent Sequana Medical at the event?

The CEO and CFO of Sequana Medical will be present, along with their Investor Relations team.

3. What is the alfapump?

The alfapump is an innovative system developed by Sequana Medical for treating fluid overload in patients.

4. When is Sequana Medical planning to launch the alfapump in the U.S.?

The launch is scheduled for mid-Q3 2025.

5. How can I contact Sequana Medical for more information?

You can reach out via their investor relations email at IR@sequanamedical.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GomSpace's €8M Lunar Deal Pushes Mission Ambitions

Updated Category News Views 63

Moon hardware is where small-space dreams either grow teeth or chew through cash, and GomSpace has just taken another meaningful bite. The company has secured an €8 million, or 89.1 million Swedish kronor, contract for the second phase of a lunar mission program with an unnamed leading North American space company. For GOMX, this is not some vague laboratory...

Continue Reading
Zoomcar's November 23 Report Puts Execution on Trial

Updated Category News Views 89

A Date on the Board, Not a Verdict November 23 is when Zoomcar finally has to put some fresh numbers beside the story. The Bengaluru-based peer-to-peer car-sharing marketplace says it will release second-quarter fiscal 2027 financial and operating results that Monday, covering the quarter ended September 30, 2026. Management also plans a live webcast at 8:00 a.m. Eastern...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 51

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 64

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Refund Delays Are Becoming an E-Commerce Sales Risk

Updated Category News Views 139

A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 65

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 24

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
2027 Auto Brand Awards Put Long-Term Buyer Value First Again

Updated Category News Views 81

Car shoppers staring down high prices and financing costs do not need another shiny badge; they need some help separating durable value from showroom wallpaper. That is why the 2027 U.S. News vehicle brand awards, announced Nov. 19, 2026, are worth a look. They are not a sales forecast, not a profit forecast, and certainly not a reason to blindly crown a corporate winner....

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 108

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenwave Technology's Bold $4 Million Rare Earth Metals Strategy

Updated Category News Views 181

Greenwave Technology Solutions Takes Bold Steps Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) recently announced a significant initiative to enhance its capabilities in rare earth metals recovery. This strategy entails raising $4 million through a securities purchase agreement with institutional and accredited investors. With a current market capitalization of...

Continue Reading
Exploring NewAmsterdam Pharma's Breakthrough Alzheimer’s Findings

Updated Category News Views 164

NewAmsterdam Pharma Unveils Exciting Alzheimer’s Data NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) has made strides in the study of Alzheimer’s disease. During a recent conference, the company presented compelling data from its BROADWAY trial, focusing on significant reductions in key Alzheimer’s biomarkers. This innovative research highlights obicetrapib's...

Continue Reading
Persistent Systems Reports Impressive Q3 Growth and Innovation

Updated Category News Views 202

Persistent Systems Achieves Strong Financial Performance Declares interim dividend of ?20 per share Persistent Systems (BSE: 533179) (NSE: PERSISTENT) has announced impressive financial results for the quarter ending December 31, showcasing a total revenue of $360.2 million. This success marks a 4.3% increase quarter-over-quarter and an outstanding 19.9% year-over-year...

Continue Reading
Nasdaq Announces Market Closure in Tribute to President Carter

Updated Category News Views 122

Nasdaq to Honor President Carter with Market Closure In a significant gesture of respect, Nasdaq (NASDAQ:NDAQ), a prominent market operator, will close all U.S. equities and options markets on January 9, 2025. This closure comes in memory of the former President Jimmy Carter, honoring his profound impact on American society. The announcement coincides with the nation’s...

Continue Reading
How a $100 Investment in Tenet Healthcare Could Grow Today

Updated Category News Views 187

The Remarkable Journey of Tenet Healthcare Tenet Healthcare (NYSE: THC) has shown impressive growth and resilience over the past 15 years. On average, the company has outstripped market returns by 5.36% annually, delivering an average annual return of 17.55%. With a current market capitalization of $17.35 billion, Tenet has proven to be a strong player in the healthcare...

Continue Reading